A stock shortage is defined as the impossibility for a person entitled to source a veterinary medicinal product on the national market.

A shortage shall be assessed as critical when it is likely to cause a risk to animal health and welfare, or even indirectly to human health.

Shortages likely to be critical must be reported by the operating laboratories as upstream as possible before they occur to the Anses — ANMV, in order to study potential alternatives.

Statement form and follow-up of shortages

Any declaration of stock shortage should be sent to the inspection, surveillance and pharmacovigilance department on the mailbox: DQ_ANMV@anses.fr